Myocardial infarction (MI) is common and affects a significant number of people annually. Death occurs due to either arrhythmia or heart failure. As leucocytosis, especially elevated neutrophil count, is a hallmark of inflammatory reactions in patients with MI, we investigated the relationship between leucocytosis on admission and left ventricular ejection fraction (LVEF) in patients with acute MI (AMI).
INTRODUCTION

Myocardial infarction (MI) is common and affects a significant
proportion of the population each year. Death in these patients is due to either arrhythmia or heart failure.
(1) Left ventricular (LV) systolic dysfunction is a prevalent complication following MI, and it is associated with a high mortality rate. (2) In these patients, the incidence of reinfarction is considerable. (3) The post-infarction inflammatory process and alterations in the involved area cause a change in the morphology, size and thickness of the infarct and non-infarct areas, and it is these processes and the associated changes that are a harbinger of LV systolic dysfunction, known as remodelling. (1) The determination of LV function using echocardiography is therefore valuable in predicting the prognosis and comparable to angiographic studies. (1, 4) The nonspecific reaction to MI is accompanied by an elevation of blood leucocytes, especially neutrophils that are increased in the first few hours of infarction and return to normal within a week.
It is not yet known whether such leucocytosis can contribute to myocardial damage. (1, 4) However, leucocytes, especially neutrophils, are an indicator of the intensity of the inflammatory reaction. Some authors have observed that leucocytosis on hospital admission is related to subsequent LV systolic dysfunction and heart failure, while others have suggested that leucocytosis is a predictive factor for heart failure. (5) (6) (7) (8) (9) (10) As leucocytosis was found to be linked in some studies to the progression of MI, deterioration of complications and increased mortality, white blood cells (WBCs) and neutrophils have been suggested to be an independent factor of prognosis in patients with MI. (5) As neutrophils can partly cause vascular damage, their count may also reflect the severity of this process.
(
The authors found a paucity of literature based on studies that completely and simultaneously investigated all the factors reported to be associated with MI in a design matched for risk factors, age and gender. In view of the abovementioned observations and the probable relationship between leucocytosis, neutrophilia and monocytosis on admission in patients with MI and the major complications seen in them (such as LV systolic dysfunction), this study was designed so that prompt and aggressive measures could be taken to treat such patients in case a relationship was established.
METHODS
A case-control study was conducted at Fatemieh Hospital, 
DISCUSSION
Recent studies have shown that inflammation plays a major role in atherosclerosis and acute coronary syndrome. (12) Sabatine et al found that leucocytes caused altered stress-induced adhesion (such as stress ischaemia, and acute and chronic endothelial damage) and bonding with toxic oxygen moieties or proteolytic enzymes. (13) According to Murtagh and Anderson, neutrophils, monocytes and special tissue macrophages (such as those in an atherosclerotic plaque) secrete myoperoxidase, an enzyme that is secreted through the activation and degranulation of leucocytes. (14) Myoperoxidase changes low-density lipoprotein so that it is more rapidly absorbed by macrophages, increases foam cell production and decreases nitric oxide. According to these authors, high levels of myoperoxidase in leucocytes and circulation is an important prognostic factor in cardiac patients. (14) The association between leucocyte count and cardiac disease has been known for years. Elevated leucocyte counts can increase cardiac disease, cardiac events in unstable angina and patients with MI, and are associated with increased mortality. (15) (16) (17) Several studies have investigated the relationship between leucocytosis and heart failure, or its effect on the short-and longterm prognosis in patients with MI. (18) (19) (20) According to Grzybowski et al, leucocytosis is associated with complications such as cardiac failure, cardiogenic shock and in-hospital death, and is an important predictive factor for intrahospital complications.
Various studies have also reported that leucocytosis is an independent factor for reinfarction, and intrahospital and onemonth mortalities. (3, 14, (21) (22) (23) (24) As leucocyte assessments are cheap and routinely performed, some authors have suggested that these should be used for risk stratification of such patients. (5, 21) Antman and Braunwald, as well as Green et al, have proposed that leucocyte elevation is a sensitive test for the diagnosis of MI, as it is associated with impaired perfusion in the epicardium and myocardium. (4, 10) This was supported by Hansen's study, which found that an elevated WBC count was accompanied by decreased epicardial and myocardial perfusion, thromboresistance (delayed patency of the artery and more thrombus formation) and a higher likelihood of cardiac failure and death. (23) Elevated leucocyte counts have been shown to be associated with resistance to thrombolysis and vessel patency 60 minutes and 90 minutes after the administration of thrombolytics, as well as increased thrombus formation following patency in patients with acute MI. (25) Defective microvascularity has also been noted in association with leucocytosis. (26) A possible explanation for this could be that, following MI, leucocytes generated from tissue necrosis are less flexible and fail to completely cross the microcirculation. This may worsen ischaemia and enlarge the infarct area, as leucocytes are larger and stiffer than red blood cells and platelets, and can therefore occlude small arteries. (27) According to Mueller et al, hypercoagulability, endothelial dysfunction, necrosis of proinflammatory myocytes and a 'no-reflow' phenomenon are all associated with leucocytosis. (21) Additionally, during reperfusion of the ischaemic tissue, neutrophils and platelets form plaques in the microvasculature and cause no-reflow, ventricular arrhythmia, loss of vascular reserve, enlargement of the infarct area, and eventually, decreased ventricular function. (28) (29) (30) We found that leucocytosis was more common in patients with systolic dysfunction than the controls, and was significantly associated with the development of heart failure. Likewise, neutrophilia was also higher among patients with systolic dysfunction than among those without such dysfunction, and was also significantly associated with the development of heart failure. While monocytosis was higher in the controls than in patients with systolic dysfunction, the association between monocytosis and LV systolic dysfunction was not significant in our series. Our findings indicate that in the acute phase of MI, leucocytosis and neutrophilia are important predictive factors for heart failure -patients with leucocytosis were 3.60 times more likely to develop heart failure, while those with neutrophilia had a 4.29 times higher risk of developing heart failure.
In summary, leucocytosis is a nonspecific indicator of inflammation in patients with MI and should be regarded as an important predictive factor for the development of LV systolic dysfunction. Leucocytosis can be used for risk stratification of such patients. 
